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Abstract 
Purpose: To evaluate the preventive and therapeutic effects of inulin supplementation in Naval Medical 
Research Institute (NMRI) male mice fed with high fat diet. 
Methods: NMRI male mice (n = 36) were divided into three groups. Control (C1), obese (O1) and 
experimental mice (E1) were fed during 8 weeks as follows: C1 with normal rodent pellet, O1 with high 
fat diet, and E1 with high fat diet plus 20 % inulin. C2, O2, and E2 were fed as follows: C2 with normal 
rodent pellets for 12 weeks; O2 with high fat diet during 8 weeks and switched to normal rodent pellet 
during next 4 weeks; and E2 with high fat diet over a period of 8 weeks and switched to normal rodent 
pellet plus 20 % inulin for 4 weeks.  Body weight, serum glucose, triglycerides, total cholesterol, high 
density lipoprotein (HDL), low density lipoprotein (LDL), and hepatic α-amylase gene expression were 
measured. 
Results: Groups receiving high fat diet showed higher weight (30.71 ± 0.66 g in O2, p < 0.001), non-
fasting blood glucose levels (257.69 ± 5.10 mg/dl in O2, p < 0.001), TG (282.15 ± 1.83 mg/dl in O2, (p < 
0.001)), and cholesterol levels (335.72 ± 2.23 mg/dl in O2, (p < 0.001)), compared with control. In C2 
group, mean body weight was 25.71 ± 0.54 g, non-fasting blood level 161.54 ± 4.48 mg/dl, TG level 
214.29 ± 5.54 mg/dl, and cholesterol level 164.29 ±4.57 mg/dl. Compared to obese group, mice 
receiving inulin showed lower blood glucose levels (223.10 ± 8.7 mg/dl in E2, p < 0.001), body weight 
(27.86 ± 0.57 g in E2, p < 0.001), TG (232.14 ± 4.02 mg/dl in E2, p < 0.001) and cholesterol (249.97 ± 
2.28 in E2, p < 0.001). A slight decrease in hepatic α-amylase gene expression was observed only in 
E1. 
Conclusion: Besides its sweetening properties, inulin may also find use as a potential anti-obesity 
compound.  
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The World Health Organization (WHO) defines 
overweight and obesity as “extreme 
accumulation of body fat to an extent where it 
may have adverse effects on the health of the 
individual” [1]. Considering the global prevalence 
of obesity and its deleterious consequences, 
which ultimately leads to higher mortality rates, 
numerous studies are aiming at preventing and 
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treating this condition. In order to counteract 
obesity, lifestyle change is recommended and 
includes the use of healthier diets [2] and 
increase of physical activity. [3]. However, 
implementing such changes in patients’ lives is 
usually difficult, and alternative therapeutic 
means such as drugs, are widely sought after [4]. 
The use of artificial sweeteners has been 
proposed as a way to help weight control through 
lessening energy intake [5]. The short-term 
efficacy of these compounds is clear, but in the 
long term, some studies report an actual weight 
gain associated with these compounds’ 
consumption [6].  
 
Recently, a potentially more elaborated 
mechanism of these substances has been 
proposed. Based on this suggestion, these 
compounds would act on specific receptors, 
which are present in the taste buds, and in the 
gastrointestinal tract [7].  
 
Inulin is a polysaccharide composed of fructose 
units, found in a wide variety of plants, and 
commercially extracted from chicory roots [8]. 
Fructose was previously suggested as an 
alternate sweetener to saccharin [9], and 
assumed to be a safe product when consumed 
moderately [10]. However, recent studies 
highlight the occurrence of severe adverse 
effects linked to its consumption [11,12]. On the 
other hand, inulin is considered as a “dietary 
fiber” which could be proposed as a potentially 
healthier alternative to fructose [13].  
 
In this study, we have tested the effect of inulin 
consumption in a mouse model fed with a high 
fat diet, in order to observe the potential effect of 




Animals and experimental protocol  
 
Male NMRI mice (six weeks old) weighing 20 ± 5 
g were purchased from the Laboratory of Animal 
Research Center of the Qom Branch of Jahad 
Daneshgahi (Iran). The mice were exposed to 
light/dark cycle of 12 h, and housed in standard 
cages at 25 °C. After one week of adaptation to 
the laboratory conditions, mice were randomly 
divided into six groups (n = 6 in each 
group).These groups were treated in two 
different settings. In both settings, mice had 
unrestricted access to food. In the first setting, 
the duration of experiment was eight weeks for 
the three groups C1, O1, and E1. In the second 
setting, the total experiment duration was 12 
weeks for the three groups C2, O2 and E2.  
 
In the first setting, the C1 group (control group), 
received standard rodent chow, the O1 group 
(obese group) received high fat diet, and the E1 
group (experimental group) received high fat diet 
and inulin. Inulin (from chicory, obtained from 
Sigma-Aldrich, St. Louis, MO, USA) was 
dissolved at 20 % in distilled water and 1mL of 
this solution was given to each mouse by 
gavage. The high-fat diet was prepared 
according to previously reported methods [14,15] 
and consisted of 150 g of mouse pellet standard 
chow, 100 g roasted peanuts, 100 g milk 
chocolate, 50 g sesame crackers and 20 g 
roasted sesame (Table 1). In addition, the obese 
group was fed 420 g creamy biscuits (1388 cal) 
weekly. 
 
In the second setting, the C2 group (control 
group) was given standard rodent chow during 
the whole experimental period (12 weeks). The 
O2 group (obese group) received high fat diet 
during the first 8 weeks, and was then switched 
to normal rodent chow for the next four weeks 
(weeks 9-12 of experiment). The E2 group 
(experimental group) received high fat diet during 
the first 8 weeks, and was  switched to normal 
rodent chow and  inulin (prepared as mentioned 
above) for the next four weeks (weeks 9-12 of 
experiment). 
 
Table 1: Composition of normal and high fat diet used 













Normal 11.40 62.80 25.80 3.01 
High 
fat 
28.60 47.50 23.90 5.43 
 
The body weight of mice was measured at the 
end of the eighth and twelfth weeks in first and 
second settings respectively. At the end of the 
experiment, the animals were anesthetized and 
sacrificed Blood samples were collected and 
immediately centrifuged at 4 °C in anticoagulant-
coated centrifuge tubes (Greiner, Germany) to 
collect the serums.  All experimental protocols 
were performed in accordance with the 
international guidelines set out in the Guide for 
the Care and Use of Laboratory Animals 
(Institute of Laboratory Animal Resources) [16].  
Ethical approval (no. 176948) was provided by 
the Ethics Committee of the Department of 
Animal Biology at the Science Faculty of Science 
and Research Branch, Islamic Azad University, 
Iran. 
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Determination of biochemical parameters  
 
Total cholesterol, triglyceride, HDL, LDL and 
blood glucose of animals serum were measured 
using appropriate biochemical kits based on 
enzymatic methods (Pars Azmoon, Iran) as per 
manufacturer’s instructions. The animals were 
not fasted, and all biochemical parameters are 
indicative of a non-fasting state. 
 
Determination of α-amylase gene expression 
 
Livers were separated after mice were sacrificed. 
Liver tissue was washed 3 times by cold PBS 
and 500 mg weighed tissue was transferred to 
sterile microtubes (Eppendorf, Germany). 1 ml of 
Tris/HCl (TB; pH 7.5, 20 mM) with 0.3 mmol/L of 
phenylmethylsulfonyl fluoride (PMSF) and 1 
mmol/L of benzamidine chloride (all chemicals 
from Merck, Germany), were added to the tubes 
and the tissues were homogenized. The 
suspension was centrifuged for 20 min at 1500 
rpm and supernates were separated. The 
resulted extracts were stored at -80 °C for RNA 
extraction. Total RNA was extracted from 
hepatocytes by using Trizol (Invitrogen, USA) in 
a standard protocol and RNA purity was 
assessed by the 260/280 ratio by a NanoDrop 
2000C (Thermo Scientific, USA). From each 
sample, up to 250 ng of total RNA was subjected 
to complementary DNA synthesis random 
hexanucleotide primers and Revert AID First 
Strand cDNA Synthesis kit (Fermantas, Vilnius, 
Lithuania). Quantitative RT-PCR (duplicate 
assays) was performed on the obtained cDNA 
and HPRT housekeeping gene was used as 
internal control. The primer pair sequences were 
5´-GTG ATT AGC GAT GAT GAA CCA G-3’, 5´- 
GCA AGT CTT TCA GTC CTG TCC-3´ for HPRT 
and 5´-AAGATGTCCTACTTAAAGAACTGG-3´, 
5´-ACCCGTGTGAAACCATAAGG-3´. Reaction 
was set by mixing 30ng cDNA, 10 µL RT2 Real-
TimeTM SYBR Green/ROX PCR Master, primer 
pairs and nuclease-free water to 20 µL. Thermal 
condition was used for 40 cycles consisting of 
initial polymerase activation step at 95 ˚C for 10 
min, followed by cycles of denaturation at 95 ˚C 
for 5 s, and finally annealing and extension at 61 
˚C for 40 s. Subsequently for melting curve 
analysis, the PCR was continued by further steps 
including: 95 °C for 15 s, 61 °C for 15 s, and 95 
°C for 15 s. For all steps, ABI step One TM 
quantitative PCR system was used (Applied 




Data are reported as mean ± standard deviation 
(SD), and were analyzed by SPSS, (version 
15.0, SPSS Inc., USA) with the use of Analysis of 
Variance method (ANOVA), Fisher's least 
significant difference (LSD) and Tukey's test. 




Body weight  
 
A significant weight gain was observed in the 
obese group O1 at week 8 of the experiment in 
comparison to its control group C1 (p < 0.001). 
The O2 group showed also a significant weight 
gain at week 12 of experiment in comparison to 
its control group (C2) (p < 0.001) (Figure 1).  On 
the other hand, consumption of inulin, both in the 
preventive and treating modes (E1 and E2 
respectively), caused a decrease in weight gain 
(E1, p < 0.05), or an increase in weight loss (E2, 
p < 0.001) compared to the respective untreated 
obese groups (O1 and O2, Figure 1). Body 
weight of the E1 group has a significant 
difference with the C1 group (p < 0.001) and 
body weight of E2 group has a significant 
difference with the C2 group (p < 0.05). This 
comparison of E1 and E2 groups with their 
respective control groups show that taking inulin 




On consumption of high fat diet, blood glucose 
levels had significantly increased in the obese 
groups O1 and O2 compared to their respective 
control groups (p < 0.001, Fig 2). Inulin 
supplementation led to lower levels of blood 
glucose in both E1 and E2 groups in comparison 
to obese groups (p < 0.001, Figure 2). However, 
in E1 and E2 groups, blood glucose levels were 
higher than their respective control groups (p < 




The serum triglyceride (TG), LDL, and 
cholesterol levels of the O1 and O2 groups 
became significantly higher than their respective 
control groups, while HDL levels were lower (p < 
0.001, Figure 3). In the E1 and E2 groups that 
were taking inulin, the lipid profile was different 
with the obese groups. More specifically, for TG, 
cholesterol, and LDL, E groups had significant 
differences relative to their obese counterparts (p 
< 0.001 for TG and cholesterol, and p < 0.01 for 
LDL). TG, cholesterol and LDL levels of E groups 
showed significant difference with their 
respective control groups. The p-value was p < 
0.001 in all groups, save for E2 compared to C2 
were it was p < 0.01. HDL levels of the E1 group 
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had no significant difference with O1, while in the 
E2 group, HDL levels had increased significantly 
(p < 0.001 in comparison to O2) (Figure 3). 
 
α-Amylase gene expression 
 
Obese groups showed a significant increase in 
their liver alpha-amylase gene expression levels 
(p < 0.01 in comparison to control groups, Figure 
4). Inulin supplementation caused a difference in 
alpha-amylase gene expression level only in the 
E1 group. In the e1 group, there was a significant 
decrease of gene expression level compared to 
the O1 group (p < 0.05). Alpha-amylase gene 
expression levels were significantly higher in E1 
and E2 in comparison to the control groups (p < 
0.01 and p < 0.05 respectively). 
 
 
Figure 1: Effect of inulin on mice body weight. C1, O1, and E1: groups of the first setting, where the experiment 
duration was 8 weeks. C1 received normal rodent food, O1 received high fat diet, and E1 received high fat diet 
and 20 % inulin. C2, O2, and E2: groups in the second setting, where the total period of the experiment was 12 
weeks. C2 received normal rodent food for 12 weeks, O2 received high fat diet for 8 weeks and normal rodent 
food for the remaining 4 weeks, E2 received high fat diet for 8 weeks and normal rodent food plus 20 % inulin for 
the remaining 4 weeks.  Data are shown as mean ± SD.***p < 0.001; *p < 0.05 compared  to  control group (C); 
### p < 0.001; #p < 0.05 compared  with the obese group (O) 
 
 
Figure 2: Effect of inulin supplementation on the serum blood glucose (mg/dl) in mice. C1, O1, and E1: groups of 
the first setting, where the experiment duration was 8 weeks. C1 received normal rodent food, O1 received high 
fat diet, and E1 received high fat diet and 20 % inulin. C2, O2, and E2: groups in the second setting, where the 
total period of the experiment was 12 weeks. C2 received normal rodent food for 12 weeks, O2 received high fat 
diet for 8 weeks and normal rodent food for the remaining 4 weeks, E2 received high fat diet for 8 weeks and 
normal rodent food plus 20 % inulin for the remaining 4 weeks.  Data are shown as mean ± SD;  * **p < 0.001 
compared with the control group(C); ###p < 0.001 compared with the obese group (O) 
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Figure 3:  Effect of inulin supplementation on serum triglycerides (TG) (A), Cholesterol (B), and HDL (C) and LDL 
(D) in mice. C1, O1, and E1: groups of the first setting, where the experiment duration was 8 weeks. C1 received 
normal rodent food, O1 received high fat diet, and E1 received high fat diet and 20 % inulin. C2, O2, and E2: 
groups in the second setting, where the total period of the experiment was 12 weeks. C2 received normal rodent 
food for 12 weeks, O2 received high fat diet for 8 weeks and normal rodent food for the remaining 4 weeks, E2 
received high fat diet for 8 weeks and normal rodent food plus 20 % inulin for the remaining 4 weeks. Data are 
shown as mean ± SD; ***p < 0.001 compared with the   control group (C), **p < 0.01 compared with the control 
group, *p < 0.05 compared with the control group, ### p < 0.001 compared with the obese group, ## p < 0.01 
compared with the obese group, #p < 0.05 compared with the obese group 
 
 
Figure 4: Effect of inulin onReal time-PCR with primers specific for alpha gene expression liver amylase Amy-1. 
C1, O1, and E1: groups of the first setting, where the experiment duration was 8 weeks. C1 received normal 
rodent food, O1 received high fat diet, and E1 received high fat diet and 20 % inulin. C2, O2, and E2: groups in 
the second setting, where the total period of the experiment was 12 weeks. C2 received normal rodent food for 
12 weeks, O2 received high fat diet for 8 weeks and normal rodent food for the remaining 4 weeks, E2 received 
high fat diet for 8 weeks and normal rodent food plus 20 % inulin for the remaining 4 weeks. Data are shown as 
mean ± SD. *p < 0.05 compared with the control (C) group, ** p < 0.01 compared with the control (C) group, ## p 
< 0.01 compared with the obese (O1) group 
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Inulin is an indigestible polymer formed by 
fructose units, and a “dietary fiber”. Dietary fibers 
delay the processes of gastric emptying and 
small intestinal transit time [8]. Addition of dietary 
fibers to a high fat diet exerts a preventive effect 
on weight gain, and lowers blood glucose levels 
[17]. In our study, similar preventive effects were 
observed on weight gain and blood glucose 
levels of the mice that received inulin together 
with their high fat diet. 
 
However, inulin is also showing a “therapeutic” 
effect , when it acts as an aid into dropping 
weight and decrease of blood glucose levels in 
mice that are already obese after consuming a 
high fat diet.  Other properties have been 
previously reported for inulin including 
antioxidant and hepato protective activity [18], 
cyto protection against corticosteroid [19], and 
immune modulator function with a potential to be 
used in vaccines [20] or as an aid in cancer 
treatment [21].  As so, inulin may be considered 
to be a functional nutriment [22].  
 
A very prominent feature of inulin is a prebiotic 
property, which is being related to different 
manifestations of its effect with regard to the 
gastrointestinal tract, including a beneficial effect 
on intestinal bacteria that may provide health-
promoting effect to their hosts [23]. The use of 
inulin has been shown to improve lipid 
metabolism in rats that were fed a high fat diet 
[24]. Our results are also showing that inulin can 
correct an impaired lipid profile.  
 
Inulin is also a “prebiotic”, which increases the 
growth and activity of specific intestinal bacteria. 
The result of prebiotic supplementation is an 
improvement of gastro-intestinal problems [23]. 
Numerous studies suggest a link between the gut 
microbiota composition and obesity. In many 
reports, a difference has been observed between 
the dominant microbiome phyla of obese and 
lean mice. Accordingly, changing the microbiota 
composition through direct administration of 
bacteria (probiotics) or indirect effect of prebiotics 
leads to weight loss [24]. In a recent study, the 
use of inulin has been shown to affect the gut 
microbiota of rats that were fed a high fat diet, 
and improve lipid metabolism [25]. Our results 
are similarly showing that inulin can correct an 
impaired lipid profile.  
 
Finally, a slight inhibitory effect in alpha-amylase 
gene expression was observed when inulin was 
taken with a high-fat diet. The obese mice have 
elevated levels of alpha-amylase gene 
expression, and decreasing these levels may 
have an anti-obesity effect. However, this is a 





Inulin, which has been observed to positively 
affect several unpaired biochemical parameters 
of obese mice, may be used as an adjuvant to 
other therapies, to achieve both preventive and 
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